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ABSTRACT
Introduction Electronic prescribing (ePrescribing) 
systems can improve the quality of prescribing decisions 
and substantially reduce the risk of serious medication 
errors in hospitals. However, realising these benefits 
depends on ensuring that relevant sociotechnical 
considerations are addressed. Optimising ePrescribing 
systems is essential to maximise the associated benefits 
and minimise the accompanying risks of these large- scale 
and expensive health informatics infrastructures.
Methods We will undertake a systematic scoping 
review of the literature to identify strategies to achieve 
optimisation of ePrescribing systems. We will search 
Medline, Embase and CINAHL for the period 1 January 
2010 to 1 June 2019 and the grey literature by using 
Google Scholar. Independent reviewers will screen the 
results using predefined inclusion and exclusion criteria 
and will extract data for narrative and thematic synthesis.
Discussion This work will be published in a peer- 
reviewed journal and we will ensure that the findings are 
both accessible and interpretable to the public, academics, 
policymakers and National Health Service leaders.
InTRoDuCTIon
Globally, there is considerable policy interest 
and substantial investment being made in 
moving health systems from paper- based 
processes to digital infrastructures to improve 
patient safety and improve the quality and 
efficiency of healthcare.1 The benefit of large- 
scale digital infrastructures is most evident in 
relation to electronic prescribing (also known 
as ‘(hospital) electronic prescribing and 
medicines administration’ and ‘computerized 
physician order entry’, henceforth referred 
to as ePrescribing). These systems, with their 
embedded medication ordering and admin-
istration systems, and computerised decision 
support, have the potential to both restrict 
and hence prevent inappropriate choices 
and alert prescribers to situations in which 
patients are at increased risk of being inadver-
tently harmed.2 They also have the potential 
to facilitate cost- conscious, evidence- based 
prescribing and enable changes in the medi-
cines use process.3 Studies have however 
found that much of the evidence of benefit 
of ePrescribing systems is from the USA and 
came from the evaluations of ‘home- grown’ 
systems that have been extensively custom-
ised to the needs of local providers.4 5 Even in 
the USA, nearly all systems are now commer-
cial. Moreover, the applicability of these data 
to other international contexts is unclear, 
particularly given that healthcare providers 
are overwhelmingly choosing to implement 
‘off- the- shelf’ commercial software solutions 
in international settings.6
Realising the potential benefits of ePre-
scribing depends on optimising ePrescribing 
systems such that the available functionality 
is switched on, appropriately used, integrated 
with other relevant health information tech-
nology (IT) and aligned with clinical work-
flows. Work by our group has revealed that 
substantial reductions in clinically important 
medication errors can be achieved in ways 
that are likely to be cost- effective, but these 
are not guaranteed, with the implementation 
of the same ePrescribing software producing 
very different results in different hospitals.7 
International studies also report variable 
outcomes following the implementation 
of ePrescribing systems, with only modest 
evidence of a reduction in prescribing errors 
in some reports and also even introduction 
of new prescribing errors due to unintended 
system consequences.8 The Leapfrog Group 
developed a tool to evaluate the safety of 
ePrescribing systems and showed that hospi-
tals with longer periods since implementation 
did not have better scores on initial testing.9 
However, repeated and prospective testing 
with the tool resulted in a consistent improve-
ment in scores by an average of 4 percentage 
points per year, illustrating the benefits that 
can be achieved through optimisation.9
Health information technologies are 
increasingly being recognised as ‘systems of 
systems’, developed over time in a complex, 
iterative and evolving process.10 These systems 
cannot be formed instantaneously, but rather, 
require considerable nurturing and commit-
ment to a life- cycle perspective. Emerging 
work is now beginning to focus on ensuring 
that these large- scale and expensive health IT 








J Health Care Inform
: first published as 10.1136/bmjhci-2019-100117 on 27 January 2020. Downloaded from 
2 Williams J, et al. BMJ Health Care Inform 2020;27:e100117. doi:10.1136/bmjhci-2019-100117
Open access 
Box 1 The six stages of the Arksey and o’Malley14 
methodological framework for conducting a scoping 
review
1. Identifying the research question.
2. Identifying relevant studies.
3. Study selection.
4. Charting the data.
5. Collating, summarising and reporting the results.
6. Consultation.
desired clinical improvements.11 This led us to develop a 
conceptual overview of approaches that can be pursued 
to achieve what has been described as ‘systems optimisa-
tion’.12 This refers to organisational efforts to maximise 
the benefits and minimise the risks of using this digital 
infrastructure to plan and deliver care.
The benefits of the substantial investment in ePre-
scribing will only be realised if these systems are fully and 
efficiently optimised such that they support national medi-
cation safety, quality and efficiency goals. By conducting 
a systematic scoping review of the literature, we hope to 
identify the range of approaches that have been used to 
achieve optimisation of ePrescribing systems and assess 
the likely acceptability, resource implications, impact and 
priority of these approaches for National Health Service 
(NHS) hospitals. In addition, we will strive to understand 
how to incorporate relevant lessons in relation to systems 
optimisation into health systems at scale. Ultimately, this 
work aims to develop policy- relevant insights into how 
best to achieve optimisation of hospital ePrescribing 
systems in order to improve the safety, quality and effi-
ciency of medicines optimisation processes.
MeThoDS
We will undertake a systematic scoping review of the 
published and grey literature. A scoping review is a tech-
nique that can be applied to evidence synthesis and is 
used to map the current literature, key concepts and the 
main sources and types of evidence in a field of interest.13 
We have chosen a scoping review rather than a formal 
systematic review as our aim is to develop a comprehen-
sive overview of this landscape, which we anticipate, will 
be most useful for policymaking deliberations. Further-
more, we anticipate it will be very difficult to quantify the 
resources spent and/or effects of individual approaches 
that have been pursued. Adding in the additional step of 
formal quality assessment of papers is therefore unlikely 
to represent a cost- efficient use of resources for this partic-
ular exercise. We also think it will be highly unlikely that 
we will be able to undertake a meta- analysis of the hetero-
geneous body of evidence that is likely to be uncovered.
A six- staged scoping review framework was first devel-
oped by Arksey and O’Malley (box 1),14 and then further 
refined by Levac et al.15
In their work, Levac et al15 draw on their experience 
of using the Arksey and O’Malley14 framework when 
conducting scoping reviews and made recommendations 
that seek to enhance and clarify each of the six stages of 
the framework. In stage 1, they emphasise the importance 
of linking the research question to the purpose and envi-
sioned outcome of the work. For the second stage, they 
focus on addressing the balance between breadth and 
feasibility, and in stages 3 and 4 they highlight the impor-
tance of taking an iterative approach. Levac et al15 expand 
on stages 5 and 6, adding further rigour to the process. 
We will be integrating consultative phases throughout 
the scoping review, reflecting the importance placed by 
Levac et al15 on this final stage in the process. We propose 
to follow this updated framework as the basis for our 
scoping protocol as this will allow us, from an early stage, 
to identify and address the key considerations applicable 
to each phase of the work.
Stage 1: identifying the research question
The breadth of scoping reviews can be especially useful 
when investigating emerging or heterogeneous fields of 
research. However, wide- reaching research questions can 
lack focus, clarity and direction. To clarify and improve 
this crucial initial stage, Levac et al15 have suggested 
‘combining a broad research question with a clearly 
articulated scope of enquiry’. To achieve this and estab-
lish an effective search strategy, they suggest defining the 
concept, the target population and the health outcomes 
of interest. They also advise establishing a specific purpose 
for the work and integrating this with the envisioned 
outcome early in the planning process. Accordingly, we 
have adapted a summary of their recommendations and 
the implications for this scoping review (table 1).
Of the key considerations proposed by Levac et al,15 
we anticipate the most challenging will be to define the 
concepts of ‘ePrescribing’ and ‘optimisation’. While 
both are well- established and well- defined concepts, we 
acknowledge the interplay between ePrescribing systems 
and robotic dispensing systems deployed in pharmacies, 
and also recognise that the future of ePrescribing is likely 
to involve the use of Apps and smartphone technology. 
We will accordingly expand on the concept of ePre-
scribing to encompass this interplay with other systems 
and the potential for future development within the field. 
It is important to remember that optimisation should be 
conceptualised as a long journey through many stages, and 
the boundaries between the latter stages of implementa-
tion and optimisation are often difficult to distinguish.12 
Following the process of implementation, ePrescribing 
systems become established, and enter a period referred 
to as a stage of maintenance.16 In reality, however, the 
maintenance of ePrescribing systems should be a dynamic 
process as the system adapts to evolving challenges and is 
subjected to regular evaluation, integrated with contin-
uous cycles of improvement. We anticipate that defining 
the boundaries between implementation, optimisation 
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Table 1 A summary of the key considerations when defining the research question, and their implications for this scoping 
review15
Key considerations when defining the 
research question Implications for our scoping review
What are the important concepts to define? Must clearly define:
 ► ePrescribing: ‘The utilisation of electronic systems to facilitate and enhance 
the communication of a prescription or medicine order, aiding the choice, 
administration and supply of a medicine through knowledge and decision 
support and providing a robust audit trail for the entire medicines use 
process.’19
 ► Optimisation: ‘The activity of enhancing system capabilities and integration 
of subsystem elements to the extent that all components operate at or above 
user expectations.’20
Who is the target population? The lessons from the study should be applied to the healthcare system in the 
NHS. Included studies should therefore reflect this.
What are the outcomes of interest?  ► What are the approaches being used to achieve optimisation of ePrescribing 
systems, and in relation to these approaches what are the:
 – Resource implications (ie, time/money, and so on).
 – Likely impacts (both positive and negative).
 – Acceptability.
 ► Identify benchmark national and international hospitals and develop a detailed 
appreciation of the approaches they have pursued.
 ► Identify relevant lessons in relation to systems optimisation for widespread 
adoption across the NHS at scale.
What is the purpose of the work? The purpose of the study is to develop policy- relevant insights into how best to 
achieve ePrescribing systems optimisation in the NHS.
What is the envisioned outcome? 1. A description of the range of approaches used for optimisation.
2. A description of the types of ePrescribing systems that have been deployed in 
the trade- offs between costs and benefits.
3. A road map of relatively easy ‘quick- win’ optimisation strategies versus 
optimisation strategies that are more resource intensive and difficult to 
achieve.
4. A map of countries and health systems showing where the evidence in this 
field is originating.
5. Develop a list of the key investigators/opinion leaders in this field.
6. A short summary of included literature, to be disseminated as an available 
resource through the ePrescribing Toolkit, http://www.eprescribingtoolkit.
com/21
NHS, National Health Service.
Our scoping review will therefore focus on the strategies 
adopted beyond the phase of implementation to improve 
established ePrescribing systems (figure 1).
Stage 2: identifying relevant studies
The next stage of the work will involve developing a 
robust search strategy to identify the relevant studies 
(online supplementary appendix 1). We will search 
Medline, Embase, CINAHL and Google Scholar for the 
period 1 January 2010 to 1 June 2019. Levac et al15 suggest 
that a scoping review should be both broad and compre-
hensive, however they also recommend taking feasibility 
into consideration. 2010 has been chosen as the start 
date because this is the time from the end date of our 
previous evidence synthesis on health IT undertaken for 
NHS Connecting for Health’s Evaluation Programme.2 
On pragmatic grounds, we will focus on human studies 
published in English. The Google Scholar search engine 
will be used to search for grey literature with the first 100 
results being considered for each phrase/term searched. 
We will augment these searches of the published litera-
ture by liaising with an international panel of experts.
Stage 3: study selection
Following the initial deduplication process, we will 
follow a systematic approach to conduct the screening 
phase. Based on the titles and abstracts of studies gener-
ated from our search, independent reviewers will select 
the relevant studies based on predefined inclusion and 
exclusion criteria for further full- text analysis (box 2). 
Disagreements will be resolved through arbitration by an 
independent reviewer.
At this stage, Levac et al15 advocate taking an iterative 
approach by further refining the search strategy based 
on the abstracts retrieved. They also strongly recommend 
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Figure 1 Defining the boundaries of ‘optimisation’ for the purpose of the scoping review (adapted from Cresswell et al [16]).
Box 2 Inclusion and exclusion criteria
Inclusion criteria
 ► Primary studies or systematic reviews with a clearly defined meth-
odology that describe an approach/approaches to the optimisation 
of an ePrescribing system.
 ► The study should be set in a high- income country, as defined by the 
Organisation for Economic Co- operation and Development (OECD).22
exclusion criteria
 ► Study does not address the optimisation of an ePrescribing system.
 ► The study is an opinion piece or a review without a clearly defined 
methodology.
 ► Study takes place in a healthcare context that is not applicable to 
learning for UK National Health Service (NHS) hospitals.
 ► The country of the study is not within the OECD.22
Box 3 Two independent reviewers will record the 
following data from studies
 ► Title.
 ► Type of document.
 ► Lead author(s)/key investigator(s).
 ► Date of publication/accessed from the web.
 ► Source.
 ► Country where the study was conducted.
 ► Healthcare context/system (eg, private/government, specialty 
based/hospital wide).
 ► Purpose/objective of study.
 ► Type and version of ePrescribing system being used.
 ► Method/intervention used for systems optimisation.
 ► How was systems optimisation measured?
 ► Did the method/intervention used for systems optimisation result in 
a measurable improvement?
 ► Resource implications (eg, time/money).
 ► Impact of optimisation (positive and negative effects).
 ► Barriers and facilitators to optimisation that are identified.
 ► Lessons for optimisation.
 ► Summary.
follow this advice by reviewing titles, abstracts and full 
papers before the screening phase to ensure our search 
strategy is identifying relevant papers. By consulting 
an international panel of experts in the field of ePre-
scribing we will already have a small number of key 
papers identified for potential inclusion in the scoping 
review. Checking that our search can identify the key 
papers picked by our expert panel will be another way 
of assessing the strength of the search strategy while also 
allowing for further iteration.
Stage 4: charting the data
To chart the data, we will use a customised data extraction 
form when undertaking the full- text analysis of included 
studies (box 3).
As mentioned at the previous stage, Levac et al15 once 
again advocate an iterative approach to data charting. 
They suggest that team members should meet initially 
and collectively develop the data extraction form 
aimed at answering the research question. However, 
they acknowledge that as the researchers become more 
familiar with the data, meeting again and refining the data 
extraction form will often be necessary. In fact, in their 
paper, Levac et al15 recommend that the two researchers 
independently extract data from the first 5–10 studies 
using the data extraction form and then meet to deter-
mine whether the resulting data are sufficient for the 
research question and purpose. For this reason, the initial 
data extraction fields detailed here will be subject to iter-
ative amendment and may not reflect the final version.
In the context of this study, and especially given the 
breadth of the search strategy, we anticipate that we will 
encounter a large volume of heterogeneous literature. 
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feasibility, we propose working backwards from the most 
recently published papers using principles of data satu-
ration as we extract meaningful lessons. Saturation is a 
methodological principle from the field of qualitative 
research and is mainly used as a criterion for discontin-
uing data analysis or collection.17 While saturation as a 
concept continues to evolve,17 we identify with the 2016 
definition by Given, who considered saturation as the 
point at which ‘additional data do not lead to any new 
emergent themes’.18 This approach of inductive thematic 
saturation17 will allow the scoping review to succinctly map 
the emerging themes in this diverse field of literature.
Stage 5: collating, summarising and reporting results
Levac et al15 add further rigour to the framework initially 
set out by Arksey and O’Malley14 by dividing this phase 
into three meaningful steps:
1. Analysing the data (this should include a descriptive 
numerical summary and a thematic analysis).
2. Reporting the results.
3. Applying meaning to the results.
Reflecting the three points above, our results will be 
analysed descriptively and thematically focusing on the 
following aspects:
 ► The range of approaches that have been applied to 
the optimisation of ePrescribing systems in various 
health systems and hospitals, drawing attention to 
benchmark national and international hospitals.
 ► A high- level indicative assessment of the resource 
implications and perceived impact of these 
approaches, both positive and negative.
 ► We hope to synthesise the above data to develop 
policy- relevant insights into how best to achieve opti-
misation of NHS hospital ePrescribing systems in 
order to improve safety, quality and efficiency of medi-
cines management.
Given the heterogeneous nature of the studies that 
we anticipate encountering, quantitative analysis of the 
impact of different optimisation strategies is unlikely to 
be feasible.
Stage 6: consultation
We propose integrating consultative phases twice during 
the scoping review. Having identified patient and public 
representatives and an international panel of experts in 
the field of ePrescribing, we will invite them to join our 
research team for meetings to help shape the develop-
ment of the project and to share ideas. During the first 
consultation their insights will help guide the scope of 
the study and in the early stages will also allow us to iden-
tify areas of the grey literature to consider for inclusion. 
Sharing our preliminary findings from stage 5 with the 
panel of experts and patient and public representatives 
will help us identify any overlooked or outdated areas 
within the literature. Their involvement at this later 
stage will also help us refine our thematic analysis, and 
their input when extrapolating applicable lessons for 
policymakers, hospitals, healthcare workers and patients 
will be invaluable.
DISCuSSIon
This scoping review will be completed as the first phase 
of a wider study on the optimisation of ePrescribing 
systems commissioned by the Department of Health and 
Social Care (DHSC). Our approach to this wider phased 
programme of work will involve detailed case studies of 
leading UK and international hospitals to identify poten-
tially transferable/scalable lessons for the NHS. A series 
of expert round- table events, throughout the life course 
of the project, will help identify strategies as well as policy 
barriers and enablers for systems optimisation of ePre-
scribing software across NHS hospitals.
By following the six stages of the Arksey and O’Malley14 
methodological framework for conducting a scoping 
study, and with particular attention to the additional 
detail and refinement added by Levac et al,15 we hope that 
this scoping study will lay a broad yet considered founda-
tion for the research phases that will follow. This work 
will lead to a more comprehensive and nuanced appre-
ciation of how hospitals can maximise the benefits from 
ePrescribing systems in order to reduce the risk of iatro-
genic medication- associated harm for patients, improve 
the quality and efficiency of prescribing decisions and 
maximise return on investments. We will work closely 
with colleagues in the DHSC to ensure that the findings 
are both accessible and interpretable to policymakers and 
NHS leaders. We also hope to draw on the collaborative 
nature of this work and develop effective dissemination 
strategies with our expert panel and patient and public 
representatives. By working with stakeholders and leaders 
in the field we hope to share lessons, spark discussions 
and generate future collaboration with fellow academics. 
Patient and public representatives will take the lead in 
producing lay summaries for our research output, adding 
further value and impact to our scoping study.
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